Resultados de la búsqueda 21-30 of 282 for ������������������������������������:VB20��������������������� ������

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis · To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  4. Clinical Update - December 2008 - MC2024-1208

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  5. Hematología - Ensayos clínicos - Mayo Clinic

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  8. Estar en forma - Mayo Clinic

    News. 2025. Mayo Clinic Q and A: Water fitness -- why aqua exercise works wonders July 25, 2025, 01:45 p.m. CDT · Mayo Clinic Q&A: Why you should know your ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous prostate tissue. This ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in patients ...